MX9207349A - Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides. - Google Patents
Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides.Info
- Publication number
- MX9207349A MX9207349A MX9207349A MX9207349A MX9207349A MX 9207349 A MX9207349 A MX 9207349A MX 9207349 A MX9207349 A MX 9207349A MX 9207349 A MX9207349 A MX 9207349A MX 9207349 A MX9207349 A MX 9207349A
- Authority
- MX
- Mexico
- Prior art keywords
- osteoporosis
- parathyroid hormone
- bisphosphonates
- methods
- treatment
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title abstract 2
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 2
- 150000004663 bisphosphonates Chemical class 0.000 title abstract 2
- 239000000199 parathyroid hormone Substances 0.000 title abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención provee métodos para mejorar la masa ósea en un ser humano u otro animal que padece de osteoporosis, que comprende un período de tratamiento de 30 días, compuesto de un régimen de administración de hormona de paratiroides y un régimen de administración de bisfosfonato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80962091A | 1991-12-17 | 1991-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9207349A true MX9207349A (es) | 1993-12-01 |
Family
ID=25201804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9207349A MX9207349A (es) | 1991-12-17 | 1992-12-17 | Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5616560A (es) |
EP (1) | EP0618805A1 (es) |
JP (1) | JPH07502507A (es) |
AU (2) | AU3322593A (es) |
BR (1) | BR9206941A (es) |
CA (1) | CA2124792C (es) |
CZ (1) | CZ282889B6 (es) |
FI (1) | FI942884A0 (es) |
HU (1) | HUT68010A (es) |
IL (1) | IL104108A (es) |
MA (1) | MA23079A1 (es) |
MX (1) | MX9207349A (es) |
NO (1) | NO942241D0 (es) |
NZ (1) | NZ246456A (es) |
RU (2) | RU2112515C1 (es) |
SK (1) | SK74594A3 (es) |
WO (1) | WO1993011786A1 (es) |
ZA (1) | ZA929758B (es) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3322593A (en) * | 1991-12-17 | 1993-07-19 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
WO1994009017A1 (en) * | 1992-10-09 | 1994-04-28 | The Upjohn Company | Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
KR970705399A (ko) * | 1994-09-09 | 1997-10-09 | 레이셔 야코버스 코넬리스 | 골다공증용 포스포네이트 및 부갑상성 호르몬(phosphonates and parathyroid hormone for osteoporosis) |
AU686458B2 (en) * | 1994-09-09 | 1998-02-05 | Procter & Gamble Company, The | Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
US5747456A (en) * | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
JPH10511095A (ja) * | 1994-12-19 | 1998-10-27 | ベス イスラエル ディーコネス メディカル センター インコーポレイテッド | 副甲状腺ホルモン又はその作動薬の低用量継続投与 |
CA2208714C (en) * | 1994-12-28 | 2003-10-21 | Gador S.A. | Bone mass anabolic composition comprising olpadronate |
US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
EP0891779A1 (de) * | 1997-06-19 | 1999-01-20 | Roche Diagnostics GmbH | Pharmazeutische Kombinationspräparate enthaltend Parathyroidhormon und Calcium- und/oder Phosphatverbindungen |
SE9702401D0 (sv) | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6770623B1 (en) * | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
EP0922467A3 (en) * | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretic drug delivery |
JP4486256B2 (ja) * | 1998-10-22 | 2010-06-23 | ザ・ジェネラル・ホスピタル・コーポレイション | 副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体 |
WO2000032771A1 (en) * | 1998-11-30 | 2000-06-08 | The General Hospital Corporation | Pth1r and pth3r receptors, methods and uses thereof |
SE9901572D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
AU2001274109B2 (en) | 2000-06-20 | 2004-12-23 | Novartis Ag | Method of administering bisphosphonates |
CA2347330C (en) * | 2001-05-10 | 2002-03-12 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
KR100491737B1 (ko) * | 2001-07-20 | 2005-05-27 | 주식회사 한국아이템개발 | 공기 정화 기능의 모기 퇴치기 |
EP1439854B1 (en) | 2001-07-23 | 2016-12-14 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
BRPI0211932B1 (pt) * | 2001-08-17 | 2016-12-06 | Novartis Ag | composição farmacêutica na forma de dosagem sólida para liberação oral, e uso de sal dissódio de ácido n-(5-cloro-saliciloil)-8-aminocaprílico (5-cnac) |
JP2005531532A (ja) * | 2002-04-05 | 2005-10-20 | メルク エンド カムパニー インコーポレーテッド | アレンドロナートおよびビタミンd製剤を用いる骨吸収阻害法 |
RU2387451C2 (ru) | 2002-05-10 | 2010-04-27 | Ф.Хоффманн-Ля Рош Аг | Бисфосфоновые кислоты, предназначенные для лечения и профилактики остеопороза |
US20040097468A1 (en) * | 2002-11-20 | 2004-05-20 | Wimalawansa Sunil J. | Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment |
US7795220B2 (en) * | 2003-03-19 | 2010-09-14 | The General Hospital Corporation | Conformationally constrained parathyroid hormones with alpha-helix stabilizers |
PL1635875T3 (pl) * | 2003-06-26 | 2009-03-31 | Psivida Inc | System dostarczania leków poprzez żelowanie w warunkach in-situ |
US7910544B2 (en) | 2003-07-17 | 2011-03-22 | The General Hospital Corporation | Conformationally constrained parthyroid hormone (PTH) analogs |
KR20060056975A (ko) * | 2003-08-06 | 2006-05-25 | 로디아 인코포레이티드 | 뼈 성장 촉진방법 |
US20050043359A1 (en) * | 2003-08-20 | 2005-02-24 | The Procter & Gamble Company | Kit for treatment of upper gastrointestinal tract conditions |
US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
CN101355959B (zh) * | 2005-11-10 | 2013-02-27 | 密歇根理工大学管理委员会 | 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法 |
EP2054077A4 (en) * | 2006-08-04 | 2010-10-13 | Gen Hospital Corp | POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) |
NZ581097A (en) * | 2007-05-24 | 2012-03-30 | Ablynx Nv | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
RU2506274C2 (ru) * | 2007-08-01 | 2014-02-10 | Дзе Дженерал Хоспитал Корпорейшн | Способы скрининга с применением g-белок сопряженных рецепторов и родственных композиций |
EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
EP2569003B1 (en) | 2010-05-13 | 2017-10-25 | The General Hospital Corporation | Parathyroid hormone analogs and uses thereof |
WO2016163886A2 (en) | 2015-04-10 | 2016-10-13 | Clues2Cure International B.V. | Administration of taurine or an analog thereof for the treatment of nerve cell damage |
EP3875105A4 (en) * | 2018-10-29 | 2022-06-29 | Asahi Kasei Pharma Corporation | Method for preventing or treating osteoporosis characterized by administering teriparatide or salt thereof twice a week |
CN111447943A (zh) | 2018-10-29 | 2020-07-24 | 旭化成制药株式会社 | 以按每周2次的频率给予特立帕肽或其盐为特征的骨质疏松症的预防或治疗方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4086196A (en) * | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
DE3243358A1 (de) * | 1982-11-24 | 1984-05-24 | Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch | Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose |
US4812311A (en) * | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Kit for use in the treatment of osteoporosis |
US4822609A (en) * | 1984-12-21 | 1989-04-18 | The Procter & Gamble Company | Treatment of osteoporosis |
US4812304A (en) * | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Treatment of osteoporosis |
IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
AU3322593A (en) * | 1991-12-17 | 1993-07-19 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
-
1992
- 1992-12-15 AU AU33225/93A patent/AU3322593A/en not_active Withdrawn
- 1992-12-15 SK SK745-94A patent/SK74594A3/sk unknown
- 1992-12-15 CA CA002124792A patent/CA2124792C/en not_active Expired - Fee Related
- 1992-12-15 WO PCT/US1992/010869 patent/WO1993011786A1/en not_active Application Discontinuation
- 1992-12-15 EP EP93901282A patent/EP0618805A1/en not_active Withdrawn
- 1992-12-15 JP JP5511155A patent/JPH07502507A/ja active Pending
- 1992-12-15 BR BR9206941A patent/BR9206941A/pt not_active Application Discontinuation
- 1992-12-15 RU RU94031209A patent/RU2112515C1/ru active
- 1992-12-15 CZ CZ941477A patent/CZ282889B6/cs not_active IP Right Cessation
- 1992-12-15 HU HU9401798A patent/HUT68010A/hu unknown
- 1992-12-15 NZ NZ246456A patent/NZ246456A/en unknown
- 1992-12-16 IL IL10410892A patent/IL104108A/en not_active IP Right Cessation
- 1992-12-16 RU RU92004521A patent/RU2104699C1/ru active
- 1992-12-16 MA MA23039A patent/MA23079A1/fr unknown
- 1992-12-16 AU AU30226/92A patent/AU663348B2/en not_active Ceased
- 1992-12-17 MX MX9207349A patent/MX9207349A/es unknown
- 1992-12-17 ZA ZA929758A patent/ZA929758B/xx unknown
-
1994
- 1994-06-15 NO NO942241A patent/NO942241D0/no unknown
- 1994-06-16 FI FI942884A patent/FI942884A0/fi unknown
-
1996
- 1996-03-20 US US08/619,103 patent/US5616560A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH07502507A (ja) | 1995-03-16 |
RU2104699C1 (ru) | 1998-02-20 |
CA2124792A1 (en) | 1993-06-24 |
FI942884A (fi) | 1994-06-16 |
NO942241L (es) | 1994-08-09 |
HUT68010A (en) | 1995-05-29 |
AU663348B2 (en) | 1995-10-05 |
RU94031209A (ru) | 1996-07-27 |
WO1993011786A1 (en) | 1993-06-24 |
ZA929758B (en) | 1993-09-10 |
NO942241D0 (no) | 1994-06-15 |
AU3322593A (en) | 1993-07-19 |
CZ147794A3 (en) | 1994-12-15 |
RU2112515C1 (ru) | 1998-06-10 |
IL104108A0 (en) | 1993-05-13 |
US5616560A (en) | 1997-04-01 |
FI942884A0 (fi) | 1994-06-16 |
BR9206941A (pt) | 1995-05-02 |
NZ246456A (en) | 1997-03-24 |
MA23079A1 (fr) | 1993-07-01 |
IL104108A (en) | 1999-09-22 |
CZ282889B6 (cs) | 1997-11-12 |
EP0618805A1 (en) | 1994-10-12 |
CA2124792C (en) | 2000-07-04 |
AU3022692A (en) | 1993-06-24 |
SK74594A3 (en) | 1995-01-12 |
HU9401798D0 (en) | 1994-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9207349A (es) | Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides. | |
BR9711829A (pt) | Implante cirúrgico contendo um marcador radiopaco ressorvìvel. | |
ZA862510B (en) | Pharmaceutical combination for increasing bone mass | |
ES2136624T3 (es) | Implante biocompatible para regular la ovulacion en yeguas. | |
GR3030076T3 (en) | Compositions for the treatment of arthritis containing phosphonates and nsaids. | |
RU92004521A (ru) | Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения | |
YU49170B (sh) | Farmaceutska formulacija na bazi paratiroidnog hormona i raloksifena | |
AU5567790A (en) | Device for reinforcing and sustaining the cap of the rotators of a human shoulder joint | |
HK1004257A1 (en) | Use of droloxifene in the treatment of bone diseases | |
ATE208612T1 (de) | Biologisch erodierbare vorrichtung zur verabreichung von wirkstoffen | |
EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
DK0480934T3 (da) | Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt | |
EP0289314A3 (en) | Use of igf-ii in the treatment of bone disorders | |
NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
RU93054017A (ru) | Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза | |
DK1001802T3 (da) | Farmaceutisk kombinationspræparat af parathyroidhormon og en knogleresorptionsinhibitor | |
KR950702120A (ko) | 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis) | |
IT1222395B (it) | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare | |
DK0561846T3 (da) | 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning | |
MX9704105A (es) | Conjunto para uso en un ciclo terapeutico de tratamiento de la osteoporosis. | |
AR001226A1 (es) | Métodos para el tratamiento de la osteoporosis utilizando fosofonatos activos y hormona paratiroidea | |
UA18990A (uk) | Зубhий імплаhтат |